Live: Broadcom (AVGO) Q4 Earnings Coverage

Investing

Endo Health Solutions : ENDP

ENDP

Stock Data

$0.00

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All ENDP Articles

103 Articles

Chris Lange | Mar 4, 2022 at 9:50 AM EST

5 Stocks That Wall Street Hates This Week

Here is another look at Beyond Meat, Foot Locker, BP Midstream and other stocks that Wall Street analysts expected little…

Chris Lange | Mar 2, 2022 at 11:50 AM EST

Wednesday Afternoon’s Top Analyst Upgrades and Downgrades: Abbott Labs, Chevron, Meta Platforms and More

Wednesday afternoon's top analyst upgrades and downgrades included Abbott Laboratories, Camping World, Chevron, Endo International, Marathon Oil, Meta Platforms and…

Chris Lange | Oct 19, 2020 at 10:53 AM EDT

Are BioSpecifics Shareholders Getting Enough in the Endo Buyout?

Are BioSpecific Technologies shareholders actually getting a good deal from the merger agreement with Endo International?

Jon C. Ogg | Jul 8, 2020 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Citigroup, Disney, Endo, JPMorgan, Livongo, Nikola, Nokia, Novavax, Transocean, Valero and More

Wednesday's top analyst upgrades and downgrades included Altria, Apple, Caterpillar, Citigroup, JPMorgan, Nikola, Nokia, Novavax, Transocean, Valero Energy, Walt Disney…

Jon C. Ogg | Jan 11, 2020 at 7:05 AM EST

20 Biopharma Stocks for Huge Upside Potential in 2020

Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.

Jon C. Ogg | Jan 7, 2020 at 2:58 PM EST

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.

Paul Ausick | Oct 1, 2019 at 12:00 PM EDT

Unusual Settlement Deal Proposed for Opioid Lawsuits

Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy…

Chris Lange | Sep 6, 2019 at 11:50 AM EDT

New Cellulite Study Submission Could Be a Big Hit

Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA…

Paul Ausick | Sep 5, 2019 at 7:50 AM EDT

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Shares of drugmaker Mallinckrodt have lost more than 40% overnight following reports that the firm has hired restructuring advisors. A…

Jon C. Ogg | Aug 27, 2019 at 11:25 AM EDT

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are…

Chris Lange | Aug 20, 2019 at 1:30 PM EDT

4 Biotechs Making Major Moves on Tuesday

Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. 24/7 Wall…

Jon C. Ogg | Aug 20, 2019 at 1:10 PM EDT

Endo Benefits Greatly From Potential Ohio Opioid Case Settlement

Endo International announced on Tuesday that its Endo and Par Pharma subsidiaries have reached a settlement in principle with the…

Jon C. Ogg | Jul 11, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Allstate, Bed Bath & Beyond, Best Buy, Blue Apron, Costco, Home Depot, Microsoft, Take-Two, Target, Walmart and More

The top analyst upgrades, downgrades and initiations on Thursday included Allstate, Bed Bath & Beyond, Best Buy, Blue Apron, Costco…

Jon C. Ogg | Jun 17, 2019 at 8:53 AM EDT

Top Analyst Upgrades and Downgrades: DBV Tech, Keurig Dr. Pepper, Deere, Dow, GNC, Kinder Morgan, Mosaic, Symantec, Walt Disney and More

Stocks were indicated to open marginally higher on Monday after gains of about 0.4% for the Dow and S&P 500…

Jon C. Ogg | Jun 11, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook,…

1 2 3 … 7

Endo Health Solutions : ENDP

ENDP

$0.00

All ENDP Articles

5 Stocks That Wall Street Hates This Week

Wednesday Afternoon’s Top Analyst Upgrades and Downgrades: Abbott Labs, Chevron, Meta Platforms and More

Are BioSpecifics Shareholders Getting Enough in the Endo Buyout?

Top Analyst Upgrades and Downgrades: Apple, Citigroup, Disney, Endo, JPMorgan, Livongo, Nikola, Nokia, Novavax, Transocean, Valero and More

20 Biopharma Stocks for Huge Upside Potential in 2020

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Unusual Settlement Deal Proposed for Opioid Lawsuits

New Cellulite Study Submission Could Be a Big Hit

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

4 Biotechs Making Major Moves on Tuesday

Endo Benefits Greatly From Potential Ohio Opioid Case Settlement

Top Analyst Upgrades and Downgrades: Allstate, Bed Bath & Beyond, Best Buy, Blue Apron, Costco, Home Depot, Microsoft, Take-Two, Target, Walmart and More

Top Analyst Upgrades and Downgrades: DBV Tech, Keurig Dr. Pepper, Deere, Dow, GNC, Kinder Morgan, Mosaic, Symantec, Walt Disney and More

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Live: Broadcom (AVGO) Q4 Earnings Coverage

Can AppLovin Become A $1 Trillion Company

Rocket Lab’s $554M Revenue Dwarfs AST SpaceMobile’s $18M Despite Identical $30B Valuations

Reddit’s Top AI Stocks: Why Traders Are Backing IBM and ASML Over other AI Plays

Suze Orman vs. Dave Ramsey on Social Security: Who’s Right?

Social Security Cost Of Living Adjustment (COLA) Changes After Fed Cuts Rates Again

Can AppLovin Become A $1 Trillion Company

Rocket Lab’s $554M Revenue Dwarfs AST SpaceMobile’s $18M Despite Identical $30B Valuations

Endo Health Solutions : ENDP

ENDP

$0.00

All ENDP Articles

5 Stocks That Wall Street Hates This Week

Wednesday Afternoon’s Top Analyst Upgrades and Downgrades: Abbott Labs, Chevron, Meta Platforms and More

Are BioSpecifics Shareholders Getting Enough in the Endo Buyout?

Top Analyst Upgrades and Downgrades: Apple, Citigroup, Disney, Endo, JPMorgan, Livongo, Nikola, Nokia, Novavax, Transocean, Valero and More

20 Biopharma Stocks for Huge Upside Potential in 2020

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Unusual Settlement Deal Proposed for Opioid Lawsuits

New Cellulite Study Submission Could Be a Big Hit

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

4 Biotechs Making Major Moves on Tuesday

Endo Benefits Greatly From Potential Ohio Opioid Case Settlement

Top Analyst Upgrades and Downgrades: Allstate, Bed Bath & Beyond, Best Buy, Blue Apron, Costco, Home Depot, Microsoft, Take-Two, Target, Walmart and More

Top Analyst Upgrades and Downgrades: DBV Tech, Keurig Dr. Pepper, Deere, Dow, GNC, Kinder Morgan, Mosaic, Symantec, Walt Disney and More

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Live: Broadcom (AVGO) Q4 Earnings Coverage

Can AppLovin Become A $1 Trillion Company

Rocket Lab’s $554M Revenue Dwarfs AST SpaceMobile’s $18M Despite Identical $30B Valuations

Reddit’s Top AI Stocks: Why Traders Are Backing IBM and ASML Over other AI Plays

Featured Reads

Suze Orman vs. Dave Ramsey on Social Security: Who’s Right?

Social Security Cost Of Living Adjustment (COLA) Changes After Fed Cuts Rates Again